Blood group typing market forecast to hit $6.46 billion by 2030

The global blood group typing market is projected to climb from $3.93 billion in 2026 to $6.46 billion by 2030, driven by more transfusions, more automation and broader use of molecular testing. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Blood group typing is a core safety step for blood transfusions and donations. - Faster growth in transfusions, surgical procedures and lab testing is expanding demand for accurate blood matching. - The market outlook points to wider adoption of automated and molecular diagnostics that could improve transfusion safety.

What happened: - The Business Research Company released a blood group typing market report on July 29, 2026. - The report says the market will rise from $3.46 billion in 2025 to $3.93 billion in 2026. - The report forecasts the market will reach $6.46 billion by 2030. - The report projects a 13.9% CAGR from 2025 to 2026 and a 13.2% CAGR through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Blood group typing identifies antigens on red blood cells to determine a person's blood type. - The process helps match donors and recipients to reduce the risk of adverse transfusion reactions. - Historical growth has been supported by higher blood donations and more transfusion procedures. - The report cites hospital laboratory growth, more surgeries, stronger donation screening and standardized transfusion protocols as past drivers. - Future growth is expected to come from wider use of molecular typing, rapid compatibility testing, laboratory automation and investment in transfusion safety systems. - The report highlights growing use of automated blood typing systems, high-throughput testing platforms, advanced reagents and kits, and molecular typing methods. - A CDC report from February 2024 said the United States has about 7 million blood donors and more than 14 million blood units transfused annually. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also said its 2026 market reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis. - The source offers a free sample of the report. - The source also links to the full market report.

Between the lines: - The report suggests blood typing is shifting from a routine lab function toward a more automated diagnostics category. - The strongest growth signals point to safety, speed and workflow efficiency rather than new clinical use cases. - Regional growth outside North America likely reflects expanding healthcare infrastructure and lab capacity, though the release does not quantify those drivers.

What's next: - The market is expected to keep growing as hospitals and labs adopt more rapid and automated testing systems. - Molecular typing and high-throughput platforms are likely to gain more share if transfusion volumes keep rising. - The report positions transfusion safety as a continuing investment area for healthcare providers and diagnostics vendors.